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Vero  cells  were  grown  adherent  to microcarriers  (Cytodex  1; 3 g  L−1)  using  animal  component  free  media
in  stirred-tank  type  bioreactors.  Different  strategies  for  media  refreshment,  daily  media  replacement
(semi-batch),  continuous  media  replacement  (perfusion)  and  recirculation  of  media,  were  compared
with  batch  cultivation.  Cell  densities  increased  using  a  feed  strategy  from  1 ×  106 cells  mL−1 during
batch  cultivation  to  1.8,  2.7  and 5.0  ×  106 cells  mL−1 during  semi-batch,  perfusion  and  recirculation,
respectively.
The  effects  of  these  different  cell  culture  strategies  on subsequent  poliovirus  production  were  investi-
gated.  Increased  cell  densities  allowed  up  to 3 times  higher  d-antigen  levels  when  compared  with  that
obtained  from  batch-wise  Vero  cell  culture.  However,  the  cell  speciﬁc  d-antigen  production  was  lower
when  cells  were  infected  at higher  cell densities.  This  cell density  effect  is in good  agreement  with  obser-
vations  for  different  cell  lines  and  virus  types.  From  the  evaluated  alternative  culture  methods,  application
of  a  semi-batch  mode  of operations  allowed  the highest  cell  speciﬁc  d-antigen  production.
The  increased  product  yields  that  can easily  be  reached  using  these  higher  cell density  cultivation
methods,  showed  the  possibility  for  better  use  of bioreactor  capacity  for  the  manufacturing  of  polio
vaccines  to  ultimately  reduce  vaccine  cost  per dose.  Further,  the  use  of  animal-component-free  cell- and
virus  culture  media  shows  opportunities  for modernization  of  human  viral  vaccine  manufacturing.
© 2014  Published  by Elsevier  Ltd. Open access under CC BY license.. Introduction
Recently, we have produced Sabin-IPV (inactivated polio vac-
ine based on attenuated Sabin strains) clinical lots under cGMP for
hase I safety (and indicative immunogenicity) studies in human
dults and infants [1,2]. The applied production process was based
n a scale-down model of the Salk-IPV manufacturing process [3].
he use of this scale-down model allowed fast development of a
rst generation Sabin-IPV, for which the speciﬁcations are closely
elated to that for the regular IPV product [2]. Parallel to this fast-
rack development an optimization and modernization research
rogram for the manufacturing of Sabin-IPV was started. Exam-
les of modernization are replacement of the used animal derived
omponents (e.g. bovine serum and porcine trypsin) and antibi-
tics. These components should preferably be omitted (for the
∗ Corresponding author at: Institute for Translational Vaccinology, Process Devel-
pment, PO BOX 450, 3720 AL Bilthoven, The Netherlands, Tel.: +31 30 274 2360.
E-mail address: wilfried.bakker@intravacc.nl (W.A.M. Bakker).
ttp://dx.doi.org/10.1016/j.vaccine.2014.02.022
264-410X © 2014 Published by Elsevier Ltd. Open access under CC BY license.antibiotics primarily to prevent any potential allergic reaction), or
respectively replaced by animal component free (ACF) alternatives
to minimize the risk of adverse effects (e.g. the potential transfer of
viruses and/or prions). Moreover, a better scientiﬁc understanding
of the process, resulting in improved process control and ability for
troubleshooting, can be created. Optimization improvements can
possibly be found in the currently used, low cell densities (1 × 106
cells mL−1). Assuming comparable virus quality and yields per cell,
the use of increased cell densities can potentially result in more
efﬁcient use of bioreactor capacity, and ultimately reduce the cost
per dose. The demand for IPV is increasing as in 2012 the WHO
SAGE group advised all countries to introduce at least one dose IPV
in their routine immunization schedules [4]. With the increased
IPV demands, which will further increase after oral polio vaccine
(OPV) cessation, the production capacity will have to increase by
scale-up and optimization causing the current IPV price of $ 3.00
per dose to decrease to $ 0.52–$ 1.95 [5]. This is still four to ﬁfteen
times the current price of OPV (cost per dose $ 0.14), the vaccine
used in most countries. Process optimization for IPV manufactur-
ing will be needed to be able to further reduce manufacturing costs
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elow $ 0.50 to keep polio vaccination economically feasible when
witching from OPV to IPV [6].
Here we report initial studies where four different adherent
ero cell cultivation methods were applied using ACF cell cul-
ure media: (i) batch, the currently used method for Sabin-IPV
reparation; (ii) semi-batch, where daily media refreshments were
pplied; (iii) perfusion where continuous media refreshment was
pplied; and (iv) recirculation where media was circulated through
he bioreactor and re-used. With these commonly known cell
ulture methods [7] higher cell densities were obtained and the
ubsequent virus culture, also using ACF virus culture media, pro-
uced higher quantities of infectious and immunogenic poliovirus.
. Materials and methods
.1.  Cells, virus
Vero  cells obtained from WHO  (10-87) originally derived
rom ATCC (CCL-81) were used as host for poliovirus production.
oliovirus seeds [1] Sabin type 1 (LSc 2ab KP2; SO + 3), Sabin type
 (P712 Ch2ab-KP2; SO + 3) and Sabin type 3 (Lot 457-III-Pﬁzer;
SO3) were used.
.2.  Cultivation methods
.2.1.  Pre-cultures
Vero  cells were cultured in T-ﬂasks and Hyperﬂasks (Corning) in
P-SFM (Invitrogen) to expand the cell number. After trypisiniza-
ion (TrypLE Select; Invitrogen) cells were resuspended in VP-SFM
nd added to the bioreactor.
.2.2.  Bioreactor Vero cell cultures
Different cultivation methods have been applied where Vero
ells were grown adherent to microcarriers (3 g L−1 Cytodex 1; GE
ealthcare). The cultures were maintained at pH 7.2, 37 ◦C, 50%
issolved oxygen (DO) by headspace aeration only (1 L min−1) and
ampled at least once a day.
Cell cultures were carried out in standard glass stirred-tank type
ioreactors, optionally equipped with a spin ﬁlter (70 m)  to retain
ells on microcarriers in the bioreactor when needed (perfusion
nd recirculation culture mode). Alternatively, a harvest pipe with
 75 m sieve was used to remove media while retaining micro-
arriers. Cultivations were controlled using Sartorius DCU-3 control
nits and MFCS-win software (Sartorius AG, Melsungen, Germany).
Batch cultivations were carried out at 4 L working volume with
noculation densities of 0.1 × 106 cells mL−1. During cultivation,
lucose and glutamine were added by bolus feeding to 10 mM glu-
ose and 2 mM glutamine when concentrations were below 5 mM
nd 0.5 mM respectively.
Semi-batch cultivations were essentially performed as
escribed by Mendonc¸ a (1998) [8] at 3 L working volume with an
noculation density of 0.1 × 106 cells mL−1. From day two  onwards,
aily 1 L culture medium (1/3 culture volume) was  replaced with
resh medium. Media replacement was done after sedimentation
f the microcarriers without agitation. In addition, bolus feeding
f glucose and glutamine was done once 4 days after the start of
ultivation to obtain concentrations of 20 mM glucose and 2 mM
lutamine.Perfusion cultivations were carried out using 1.5 L working vol-
me. Cells were inoculated at 0.1 × 106 cells mL−1 and retained in
he bioreactor. After 2 days of batch cultivation, continuous media
eed was started at 1.5 L day−1 (1 culture volume per day). Media
eed rate was kept constant for the remainder of the perfusion
ultures. 32 (2014) 2782–2788 2783
Recirculation cultures, where cells are retained in the bioreac-
tor (3 L working volume) while medium (15 L total volume = culture
volume + circulated volume) is circulated, were carried out essen-
tially as described previously [9]. Cells were inoculated at a cell
density of 0.6 × 106 cells mL−1. After 1 day, a continuous recircu-
lation ﬂow was  started with 15 L day−1 (5 culture volumes per
day), followed by daily increments to 22 L day−1 and 30 L day−1
(respectively 7.3 and 10 culture volume per day) at days 3 and 4.
2.2.3. Virus culture
Prior  to virus infection, using the same bioreactor vessel used
for Vero cell culture, the media feed was stopped and pH, DO and
temperature settings were adjusted to 7.4, 25% and 32.5 ◦C, respec-
tively. Media was  not refreshed but glucose and glutamine were fed
when concentrations were below 5 mM and 0.5 mM,  respectively.
Cells were infected with poliovirus with an MOI  (multiplicity of
infection) of 0.01. Virus cultivation was  considered ﬁnished when
100% CPE (cytopathic effect) was  observed microscopically.
2.3. Analytics
Cells were counted daily using a Nucleocounter NC-100
(Chemometec).
Cell culture metabolites such as glucose, lactate, glutamine, glu-
tamate and ammonia were monitored using a Bioproﬁle 100 Plus
(Nova Biomedical Waltham, MA).
Poliovirus was  quantiﬁed with a virus titer assay as described
previously [10]. The amount of d-antigen was  assessed using a d-
antigen ELISA [11].
3.  Results
3.1. Vero cell growth
Vero  cell cultures were performed in four different cultivation
modes, batch, semi-batch, perfusion and recirculation. Batch cul-
tivations were performed to obtain a reference growth curve for
later comparison with the more sophisticated culture methods
where either media is refreshed (semi-batch and perfusion) or cir-
culated (recirculation). After 3–4 days of cultivation, a cell density
at 1.0 × 106 cells mL−1 was reached in batch cultivation with an
average growth rate of 0.036 h−1 during exponential growth and a
growth rate of 0.022 h−1 at the moment of virus infection on day 4
(Fig. 1; Table 1). At this point cells are present as a monolayer on
the microcarriers (Fig. 2). Applying a daily partial medium renewal
in a semi-batch mode allowed cell growth to continue and after 2
additional days of culture (6 days in total) a cell density of 1.8 × 106
cells mL−1 was obtained. Here comparable growth rates to batch
cultivation were observed. The growth rate declined during the
feed phase from 0.034 h−1 at day 3 to 0.006 h−1 at day 6. Using a
perfusion mode, where medium renewal is continuous, cell growth
could be prolonged to yield a cell density of 2.7 × 106 cells mL−1 in
7 days. The growth rates of the Vero cells were lower during the
feed phase compared to the growth rates observed in semi-batch
cultivations and decreased from 0.018 h−1 at day 3 to 0.005 h−1
at day 7. Cells were present in a multilayer on the microcarriers
at these cell concentrations (Fig. 2). In the so-called recirculation
method [9] cells were retained in the bioreactor while medium
from an external container was  circulated. When starting with an
inoculation density of 0.6 × 106 cells mL−1 a monolayer was  already
formed after one day of cultivation, and cells started to grow in a
multilayer rapidly. Cell concentrations of 5.0 × 106 cells mL−1 were
found after a culture time of 4 days, while growth rates decreased
linearly during the feed phase from 0.025 h−1 at day 2 to 0.0004 h−1
at day 4. It should be noted, that the latter cultivation method was
2784 Y.E. Thomassen et al. / Vaccine 32 (2014) 2782–2788
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Fig. 1. Growth curves of Vero cells using different cultivation modes batch (B), semi-batch (S), perfusion (P) and recirculation (R). Different batches are indicated with
different grey shades and symbols, where squares, circles and triangles represent cultures that were infected with poliovirus type 1, 2 and 3 respectively. Infection of cultures
was  done at the end of the shown growth curve.
F
f
T
Cig. 2. Photographs of Vero cells on microcarriers at the time of virus inoculation. Presen
or respectively batch, semi-batch, perfusion and recirculation) is clearly visible.
able 1
ell  culture characteristics of different Vero cell cultivation methods.
Cultivation method Inoculation cell density
(×106 cells mL−1)
Cell density at tim
(×106 cells mL−1
Batch (n = 5) 0.10 ± 0.04 1.02 ± 0.07 
Semi-batch  (n = 3) 0.14 ± 0.01 1.75 ± 0.32 
Perfusion  (n = 3) 0.08 ± 0.01 2.72 ± 0.10 
Recirculation (n = 3) 0.64a ± 0.11 5.01 ± 0.40 
a Requires a larger pre-culture volume.ce of multilayers at higher cell concentrations (1.0, 1.8, 2.7 and 5.0 × 106 cells mL−1
e of infection
)
Culture time (days) Growth rate at virus
infection  (h−1)
4 0.022
6 0.006
7 0.005
4a 0.0004
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Vig. 3. Glucose (squares) and glutamine (diamonds) concentrations present in Vero
re  averaged numbers. Daily media exchange was started at day 2 (S), media feed a
pplied using higher inoculation densities, which implies that a
ore extensive (or longer) pre-culture was needed.
.2. Glucose and glutamine concentrations during cell culture
The  concentrations of glucose and glutamine were analyzed
uring the Vero cell growth in different cultivation modes. Glu-
ose and glutamine concentrations decreased rapidly when the
ulture was in batch mode (Fig. 3). When media was refreshed
aily (semi-batch) or continuously (perfusion) or when media was
irculated (recirculation), sufﬁcient glucose and glutamine were
resent during the complete cultivation time. During perfusion and
ecirculation cultivations it is clear that from the moment the feed
as started the glucose and glutamine levels remained reasonably
onstant, whereas during semi-batch cultivations glucose and glu-
amine concentrations varied more. This was directly correlated to
he feeding times. It should be noted that during semi-batch cul-
ivations, an additional bolus feed of glucose and glutamine was
iven at day 4 (Fig. 3).
.3.  Lactate and ammonia concentrationsDuring the batch cultivation lactate and ammonia concentra-
ions increased and within 3 days concentrations up to 30 mM
actate were reached. Daily media replacements allowed to keep
able 2
irus  titers and d-antigen concentrations observed using different Vero cell culture meth
Cultivation method
during  cell culture
Poliovirus type 1 Poliovirus
Virus titer (10 LOG
TCID50 mL−1)
d-antigen
(DU  mL−1)
Virus titer
TCID50 m
Batch 8.7 175 8.8 
Semi-batch  8.8 356 8.7 
Perfusion 9.3 320 8.3 
Recirculation 9.5 508 8.8 ltivations using batch (B), semi-batch (S), perfusion (P) or recirculation (R). Figures
3 (P) and circulation at day 1 (R).
lactate  concentration below 30 mM whereas continuous media
replacement lowered the lactate concentration. Recirculation of
media caused a relative constant lactate and ammonia concen-
tration during the cultivation time. Although lactate levels reach
high concentrations (above 20 mM), the Vero cell growth contin-
ued and therefore it was  concluded that this did not inhibit cell
growth severely. Ammonia concentrations were below 2 mM under
all growth conditions (Fig. 4).
3.4. Virus culture
To  determine the variability in poliovirus yields, three cell
cultures (in batch mode) were infected with poliovirus type 3.
When virus culture was  complete, virus titers were measured to
determine the amount of infectious poliovirus and d-antigen was
measured to quantify the amount of immunogenic poliovirus. The
RSD (relative standard deviations) were 9% for the virus titer and 8%
for the d-antigen concentration. Both are within 10%, which can be
considered comparable. This means that cultures were very com-
parable as the virus titer assay is valid within 0.5 log (=6%) and the
RSD for test reproducibility for the d-antigen ELISA is 10.6% [11].
Based on good virus culture reproducibility, it was chosen to com-
pare the effects of different cell culture strategies on the virus yield
with n = 1 for all three virus types.
ods before virus replication.
 type 2 Poliovirus type 3
 (10 LOG
L−1)
d-antigen
(DU  mL−1)
Virus titer (10 LOG
TCID50 mL−1)
d-antigen
(DU  mL−1)
44 8.8 ± 0.8 (n = 3) 78 ± 6 (n = 3)
72 7.9 137
65 8.6 115
115 8.9 185
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0
5
10
15
20
25
30
35
40
0 1 2 3 4 5 6 7
Time (days)
La
ct
at
e 
co
nc
en
tr
at
io
n 
(m
M
)
0
1
2
3
NH
4+
 c
on
ce
nt
ra
tio
n 
(m
M
)
S
0
5
10
15
20
25
30
35
40
0 1 2 3 4 5 6 7
Time (days)
La
ct
at
e 
co
nc
en
tr
at
io
n 
(m
M
)
0
1
2
3
NH
4+
 c
on
ce
nt
ra
tio
n 
(m
M
)
B
0
5
10
15
20
25
30
35
40
0 1 2 3 4 5 6 7
Time (days)
La
ct
at
e 
co
nc
en
tra
tio
n 
(m
M
)
0
1
2
3
NH
4+
 c
on
ce
nt
ra
tio
n 
(m
M
)
P
0
5
10
15
20
25
30
35
40
0 1 2 3 4 5 6 7
Time (days)
La
ct
at
e 
co
nc
en
tra
tio
n 
(m
M
)
0
1
2
3
NH
4+
 c
on
ce
nt
ra
tio
n 
(m
M
)
R
F cultiva
a y 3 (P
t
a
w
w
w
i
w
t
S
e
y
y
F
w
aig. 4. Lactate (squares) and NH4+ (diamonds) concentrations present in Vero cell 
veraged numbers. Daily media exchange was started at day 2 (S), media feed at da
Comparable virus titers were found independent of the cell cul-
ure method that was applied (Table 2). On the other hand, for
ll three poliovirus types differences in d-antigen concentrations
ere more pronounced. In all cases where media refreshments
ere used during cell cultures an increase of the d-antigen yield
as observed, when compared with batch-wise cell culture. These
ncreases ranged from approx. 1.5- to 2-fold when cell cultures
ere carried out in semi-batch and perfusion mode to approx. 2.4-
o 2.9-fold when cell cultures were executed in recirculation mode.
ince cell concentrations at the start of virus culture were differ-
nt in the different settings (Table 1), the cell speciﬁc d-antigen
ields were calculated and compared (Fig. 5). Cell speciﬁc d-antigen
ields were the highest when virus culture was carried out based on
0
50
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batch semi-batch perfusion recirculation
D
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ld
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U
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6  c
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)
ig. 5. Cell speciﬁc d-antigen yields (poliovirus type 1, black; type 2, grey; type 3,
hite) after different cell culture methods. Similar virus culture conditions were
pplied.tions using batch (B), semi-batch (S), perfusion (P) or recirculation (R). Figures are
) and circulation at day 1 (R).
semi-batch cell cultures for poliovirus type 1 and batch or semi-
batch cell cultures for type 2 and 3. When perfusion or recirculation
cultures were used prior to virus culture, the cell speciﬁc d-antigen
yields were a factor 2 lower.
4.  Discussion
The Vero cell line is one of the commonly used cell lines to
produce viral vaccines [12]. Classic cell culture processes used in
vaccine manufacturing are often based on batch-wise cell and virus
cultivations followed by extensive downstream processing, con-
centration, puriﬁcation and inactivation to yield a product [13,14].
While downstream processing is important, the virus of interest
is generated during upstream processing, i.e. cell and virus cul-
ture. It is also at this stage where the intrinsic product quality is
determined. Whereas product yields may  be related to both the cell
concentration and the metabolic state of the cells, product quality
is likely largely inﬂuenced by the cells metabolic condition and the
virus culture conditions. In other words, the cell culture method
may impact product quality. The cell cultures are discussed ﬁrst,
followed by the observed d-antigen levels as indicator of product
quality.
The application of different cell culture strategies resulted in
higher cell densities, up to 5 × 106 cells mL−1 during recircula-
tion cultures. These cell concentrations were at comparable levels
to those previously reported for recirculation cultures [15]. In
addition, the cell densities reached using perfusion, semi-batch
and batch cultures were comparable to those reported by others
[8,16,17].
At the higher cell densities, cells were growing in multilayers
on the microcarriers. Recently it has been reported that the tumor-
genicity of Vero cells is dependent not only on the passage level
as reported previously [18], but also on the culture conditions [19].
The growth in dense cultures as well as the adaptation to serum free
media may  result in the acquisition of a tumorgenic phenotype.
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oreover differences in cell morphology, i.e. the compactness of
he monolayer, have been reported for Vero cell growth in differ-
nt serum free media [20]. As such, tumorgenicity of the Vero cells
rowing in multilayers in a speciﬁc ACF medium should be inves-
igated before these cells are used to produce clinical materials.
During  all cell cultures, sufﬁcient concentrations of glucose and
lutamine were present. At the end of cell culture lactate concentra-
ions were high, up to 36 mM during batch, approx. 20 mM during
emi-batch and recirculation and 12 mM during perfusion cultures.
eports of high lactate concentrations during Vero cell growth are
bundant when the carbon source is glucose, see for example Petiot
t al. (2010) [17], and are caused by the overﬂow metabolism. High
actate concentrations may  be prevented by using other carbon
ources like fructose or galactose [8,17]. The ammonia concentra-
ion was around 1 mM at the end of the cultivations, which is at an
cceptable level that does not inhibit cell growth [21]. Since media
as not changed prior to virus culture, these lactate and ammonia
oncentrations were present at virus infection.
The use of VP-SFM during cell and virus culture appeared ben-
ﬁcial for virus yields when compared to cultivation using serum
ontaining medium during cell culture and M199 during virus cul-
ure. In earlier studies [1], using the latter media, d-antigen levels
eported for production at 350-L scale were 120, 25 and 56 DU mL−1
or respectively Sabin poliovirus type 1, 2 and 3. The use of VP-SFM
esulted in a 1.5 times higher level of antigenic product concentra-
ion using batch cultivations and 4 fold when using a recirculation
ulture prior to virus infection. It should be noted that here virus
ultures were carried out using spent media. Regarding the nutri-
nt and waste metabolite concentrations it might be even more
eneﬁcial to change the media prior to virus culture or to feed
ossible depleted nutrients during virus culture. This type of opti-
ization may  result in a favourable host cell metabolic condition
ith respect to virus production.
Differences  in d-antigen yield per cell between batch or semi-
atch and perfusion or recirculation were observed (Fig. 5). At
igher cell densities the virus yield per cell decreased. This might be
n example of the so-called “cell density effect” ﬁrst described by
ood et al. [22] and observed for different virus cultivation systems
16,20,23,24]. In several cases nutrient limitation or the presence
f inhibitory factors may  have caused this effect [16,23,24]. In oth-
rs, the cause remains to be found [20,25]. Here, the concentrations
f the main nutrients, glucose and glutamine, and waste products,
actate and ammonia, were at less favourable levels during batch or
emi-batch, while the highest speciﬁc product yields were observed
nder these conditions. We  thus concluded that these concentra-
ions are less relevant when compared with other phenomena that
nﬂuence the cells ability to produce virus. These other aspects
ould be the growth rate at virus infection, the presence of multilay-
rs, or the capacity (surface space) to continue growth after virus
nfection. Cell growth rates at time of virus infection were lower
nder all high cell density strategies compared to the growth rates
bserved in batch cultivations and thus do not explain for the differ-
nce in cell speciﬁc d-antigen yield observed between semi-batch
nd perfusion or recirculation cultures. Possibly, the presence of a
ultilayer has a more important negative effect. It could be that in
 multilayer not all cells present on the microcarrier support virus
eplication in the same way. Moreover, the capacity to continue
ell growth at the moment of virus infection may  be important as
he applied MOI  was 0.01 which means 99% of the cells will not be
nfected during the ﬁrst virus replication cycle and can potentially
row further. These topics are currently under investigation to be
ble to further optimize the virus culture at increased cell densities.The highest virus yields, based on d-antigen concentrations,
ere observed using the recirculation mode for cell culture. At
he ﬁrst glance, to maximize bioreactor capacity, this seems to
e the best choice. However, it should be mentioned that a larger 32 (2014) 2782–2788 2787
pre-culture  needs to be prepared as here the cell culture is started at
0.6 × 106 instead of 0.1 × 106 cells mL−1 used for the other cell cul-
ture strategies. Hence, extending the overall process throughput
time. Further, considering the cell speciﬁc d-antigen productiv-
ity, the semi-batch cell culture strategy appeared to be a good
alternative. In addition, this method can be applied in existing man-
ufacturing equipment without large investments. At present, we
are optimizing this method with respect to microcarrier concentra-
tion, feed frequency and feed/bioreactor volume ratio. In addition,
adaptation of downstream processing to concentrate and purify the
poliovirus obtained from increased cell density cultures is studied.
Focus points are the ﬁlter load with cell debris during clariﬁcation
and concentration and the removal of the increased concentrations
of host cell proteins and host cell DNA during column chromatog-
raphy. Also, product quality and immunogenicity after puriﬁcation
remains to be assessed. In that way, discrimination between intact
virus particles and virus progeny, which may  have attributed to the
observed increased d-antigen levels, can be made.
5.  Conclusions
This study shows that adherent Vero cell culture using differ-
ent methods of medium refreshment allows higher cell densities.
Increased cell densities allowed up to 3 times higher d-antigen lev-
els when compared with that obtained from batch-wise Vero cell
culture. The cell speciﬁc d-antigen production was lower when cells
were infected at higher cell densities. Application of a semi-batch
mode of operations allowed the highest cell speciﬁc d-antigen
production, while 2 fold lower cell speciﬁc d-antigen yields were
found using perfusion or recirculation cultures. This reduction may
be related to the presence of multilayers of cells on the micro-
carriers, which were observed at higher cell densities that were
reached using perfusion or recirculation mode. In our view, the
most promising concept for polio d-antigen yield optimization
would be semi-batch cultivations. This strategy has potential to be
further improved and can be implemented in current manufactur-
ing facilities. Using the here presented method for semi-batch cell
culture and subsequent virus culture, d-antigen yields per run can
be doubled.
Concluding, the use of increased cell densities can result in more
efﬁcient use of bioreactor capacity, and may so reduce the vaccine
cost per dose.
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